The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 485.00
Bid: 485.00
Ask: 489.00
Change: 4.00 (0.83%)
Spread: 4.00 (0.825%)
Open: 481.00
High: 488.00
Low: 480.00
Prev. Close: 481.00
TET Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Chief Executive Officer

4 Mar 2024 07:00

RNS Number : 3428F
Treatt PLC
04 March 2024
 

4 March 2024

 

TREATT PLC

 ("Treatt" or "the Group")

 

Appointment of Chief Executive Officer

 

 

Treatt, the manufacturer and supplier of a diverse and sustainable portfolio of natural extracts and ingredients for the beverage, flavour and fragrance industries, today announces the appointment of David Shannon as Group Chief Executive Officer and a Director effective on 3 June 2024.

 

David joins Treatt from Croda International Plc where he has held a number of senior roles, recently as President of Consumer Care and an Executive Committee member. He has extensive experience in selling specialty ingredients in the B2B environment for the Flavour and Fragrance, Personal Care, Pharmaceutical and Agricultural industries worldwide.

 

David has a proven track record of sustainably growing businesses in dynamic markets. He has spent 13 years in various roles in the USA, a key market for Treatt, and has recently overseen a new manufacturing project in China. David's experience includes global business management, setting and delivering strategy, optimising science and innovation to drive revenue growth, identifying new ways to maximise revenue and attracting, retaining and developing employees. He has a degree in Chemistry from Edinburgh University.

 

Ryan Govender and Alison Sleight will continue as Interim CEO & Interim CFO respectively until David joins, when Ryan will resume as CFO and Alison as Group Finance & IT Director, and the Board thanks them for their continued commitment and strong contribution.

 

Vijay Thakrar, Chair of Treatt, commented:

 

"Following a robust search process that attracted a number of high quality candidates, we are thrilled that David is joining the Treatt team. He has highly relevant international experience delivering growth in an innovation led group, with a motivational and collaborative leadership style, which will enable him to lead Treatt through its next, exciting phase. The Board and I look forward to working closely with David, Ryan and our Leadership Team as they focus on realising the full potential of Treatt following the investments of recent years.

 

David Shannon added:

 

"I am honoured to be joining Treatt as CEO, a company that has a remarkable history of delivering excellence to its customers through sustainability, innovation and agility, supported by a unique culture. I am looking forward to working with everyone at Treatt to build on its strong foundation, unlock new opportunities and chart a path of sustained success."

 

The Company confirms that there is no further information to be disclosed under the requirements of Listing Rule 9.6.13 in relation to the appointment.

 

 

 

Treatt plc +44 (0)1284 702500

Vijay Thakrar Chair

Ryan Govender ? Interim Chief Executive Officer

Alison Sleight Interim Chief Financial Officer

 

Brokers

Investec Bank plc +44 (0) 20 7597 5970

Patrick Robb

David Anderson

 

Peel Hunt LLP +44 (0) 20 7418 8900

George Sellar

Mike Burke

 

Financial PR

MHP Communications +44 (0) 20 3128 8789

Tim Rowntree

Eleni Menikou

Catherine Chapman

 

About the Group

Treatt is a global, independent manufacturer and supplier of a diverse and sustainable portfolio of natural extracts and ingredients for the flavour, fragrance and multinational consumer product industries, particularly in the beverage sector. Renowned for its technical expertise and knowledge of ingredients, their origins and market conditions, Treatt is recognised as a leader in its field.

 

The Group employs over 350 staff in Europe, North America and Asia and has manufacturing facilities in the UK and US. Its international footprint enables the Group to deliver powerful and integrated solutions for the food, beverage and fragrance industries across the globe.

 

For further information about the Group, visit www.treatt.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUPUUPWUPCGMG
Date   Source Headline
16th Feb 20227:00 amRNSAppointment of Chief Financial Officer
8th Feb 20225:06 pmRNSStandard Form for notification of major holdings
28th Jan 20223:29 pmRNSResult of AGM
28th Jan 20227:00 amRNSAGM Trading Update
25th Jan 20223:50 pmRNSStandard Form for notification of major holdings
20th Jan 202212:18 pmRNSConfirmation of AGM arrangements
17th Jan 20229:36 amRNSBoard Appointments
14th Jan 20229:30 amRNSVoting Rights and Capital
20th Dec 20216:16 pmRNSNotification of Transactions of Director
16th Dec 20215:50 pmRNSNotification of Transactions of Director & PCA
14th Dec 20219:07 amRNSAnnual Report
8th Dec 20214:49 pmRNSStandard form for notification of major holdings
8th Dec 20214:46 pmRNSStandard form for notification of major holdings
6th Dec 202112:32 pmRNSNotification of Transactions of Director
6th Dec 20218:58 amRNSStandard form for notification of major holdings
1st Dec 20215:25 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Dec 20215:20 pmRNSBLOCK LISTING SIX MONTHLY RETURN
30th Nov 20217:00 amRNSFull Year Results
26th Nov 20218:25 amRNSDirector Declaration
9th Nov 20215:11 pmRNSStandard form for notification of major holdings
18th Oct 20215:58 pmRNSStandard form for notification of major holdings
18th Oct 202110:29 amRNSStandard form for notification of major holdings
15th Oct 20214:25 pmRNSStandard form for notification of major holdings
11th Oct 20217:00 amRNSTrading Update
7th Oct 20214:07 pmRNSNotification of Transactions of a PCA
4th Oct 20214:54 pmRNSTotal Voting Rights
4th Oct 202110:30 amRNSDirector/PDMR Shareholding
21st Sep 20212:25 pmRNSChange of Registered Office
21st Sep 202111:50 amRNSDirector/PDMR Shareholding
21st Sep 20219:50 amRNSHolding(s) in Company
15th Sep 20213:02 pmRNSHolding(s) in Company
9th Sep 20219:59 amRNSStandard form for notification of major holdings
8th Sep 20215:24 pmRNSNotification of Transactions of Directors and PCA
3rd Sep 20215:25 pmRNSDirector/PDMR Shareholding
2nd Sep 20215:38 pmRNSNotification of Transaction of Director & PCA
25th Aug 20211:20 pmRNSHolding(s) in Company
23rd Aug 20215:05 pmRNSHolding(s) in Company
18th Aug 202112:30 pmRNSDirector/PDMR Shareholding
17th Aug 20217:00 amRNSBoard Change
13th Aug 20216:25 pmRNSDirector/PDMR Shareholding
9th Aug 20211:50 pmRNSNotification of Transactions of Director
20th Jul 20215:50 pmRNSHolding(s) in Company
14th Jul 20214:17 pmRNSNotification of Transactions of a PCA
14th Jul 20214:15 pmRNSDirector/PDMR Shareholding
30th Jun 20217:00 amRNSBoard Update
24th Jun 20215:16 pmRNSHolding(s) in Company
10th Jun 202111:25 amRNSHolding(s) in Company
10th Jun 202110:00 amRNSBoard Change
1st Jun 20215:14 pmRNSBlock Listing Six Monthly Return
1st Jun 20215:13 pmRNSBlock Listing Six Monthly Return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.